Dexamethasone treatment is associated with a higher HBsAg sero-clearance rate in HBeAg-positive patients with hepatitis B flares
Our study confirmed the beneficial role of low-dose and short-term dexamethasone treatment in flare patients, particularly in patients with ALT ≥ 30 × ULN and platelet counts ≥ 110 × 10<sup>9</sup>/L.
Authors
- Yi Zhou (ORCID: https://orcid.org/0000-0001-9254-3245)
- Jianmei Xiao
- Guohong Deng (ORCID: https://orcid.org/0000-0003-1263-7220)
- Dongqing Gu (ORCID: https://orcid.org/0000-0002-4404-8423)
- Yan Hang Gao (ORCID: https://orcid.org/0009-0009-0537-4021)
- Wenting Tan (ORCID: https://orcid.org/0000-0002-2884-071X)
- Haoliang Wang (ORCID: https://orcid.org/0000-0003-2886-1497)
- Qing Mao (ORCID: https://orcid.org/0000-0001-9499-8470)
- Xing Wan (ORCID: https://orcid.org/0000-0003-3667-3461)
- Xiaomei Xiang
- Zhaoxia Tan
Institutions
- Army Medical University (CN)
- Southwest Hospital (CN)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.jmii.2025.08.009
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Southwest Hospital
- Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission